These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36919388)

  • 21. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute telogen effluvium associated with SARS-CoV-2 infection.
    Domínguez-Santás M; Haya-Martínez L; Fernández-Nieto D; Jiménez-Cauhé J; Suárez-Valle A; Díaz-Guimaraens B
    Aust J Gen Pract; 2020 Aug; 49():. PubMed ID: 33051638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms.
    Rossi A; Magri F; Sernicola A; Michelini S; Caro G; Muscianese M; Di Fraia M; Chello C; Fortuna MC; Grieco T
    Skin Appendage Disord; 2021 Jul; 21(5):1-5. PubMed ID: 34373830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study.
    Awad NEHA; Obaid ZM; Zaky MS; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):761-767. PubMed ID: 37704885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery From Alopecia After COVID-19.
    Otsuka Y; Nakano Y; Hagiya H; Tokumasu K; Otsuka F
    Cureus; 2022 Jan; 14(1):e21160. PubMed ID: 35165610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hair and nail manifestations of COVID-19.
    Tammaro A; Adebanjo GAR; Parisella FR; Luzi F; Scarabello A
    J Cosmet Dermatol; 2022 Apr; 21(4):1339-1346. PubMed ID: 35032337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
    Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
    JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia.
    Abdulwahab RA; Aldajani BM; Natto NK; Janabi AM; Alhijaili OI; Faqih NT; Alharbi A
    Cureus; 2022 Sep; 14(9):e29285. PubMed ID: 36277546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SYMPTOMATOLOGY AND TREATMENT OF COVID-19 AFFECTING SKIN APPENDAGES: A NARRATIVE REVIEW BEYOND COVID-TOES.
    Wollina U; Abdelmaksoud A; Chiriac A; Brzezinski P; Temiz S
    Georgian Med News; 2022 Oct; (331):78-84. PubMed ID: 36539135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID-19 Infection: A Case Series.
    İşlek A; Karaaslan E; Şimşek S; Merve Çetin F
    J Cosmet Dermatol; 2022 Feb; 21(2):590-594. PubMed ID: 34965004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia.
    Guarnieri G; Bertagna De Marchi L; Marcon A; Panunzi S; Batani V; Caminati M; Furci F; Senna G; Alaibac M; Vianello A
    Ann Med; 2022 Dec; 54(1):869-874. PubMed ID: 35341398
    [No Abstract]   [Full Text] [Related]  

  • 32. The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies.
    Weng CT; Wei KC; Yang CC
    Influenza Other Respir Viruses; 2024 Jul; 18(7):e13356. PubMed ID: 39057605
    [No Abstract]   [Full Text] [Related]  

  • 33. Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization.
    Miola AC; Florêncio LC; Bellini Ribeiro ME; Alcântara GP; Müller Ramos P; Miot HA
    J Am Acad Dermatol; 2022 May; 86(5):e207-e208. PubMed ID: 34906662
    [No Abstract]   [Full Text] [Related]  

  • 34. Telogen effluvium in the new SARS-CoV-2 era.
    Ocampo-Garza SS; Vastarella M; Nappa P; Cantelli M; Fabbrocini G
    Int J Dermatol; 2021 Jul; 60(7):e265-e266. PubMed ID: 33660272
    [No Abstract]   [Full Text] [Related]  

  • 35. Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication.
    Monari P; Gualdi G; Bettoni G; Costa R; Ragni G; Zani F; Bianchi G; Casella S; Casella E; Crippa M; Calzavara Pinton P; Di Nicola M; Porreca A; Amerio P; Guizzi P
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
    Turlier V; Darde MS; Loustau J; Mengeaud V
    J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of telogen effluvium followed by alopecia areata after SARS-CoV-2 infection.
    Kageyama R; Ito T; Nakazawa S; Shimauchi T; Fujiyama T; Honda T
    J Dermatol; 2023 Jan; 50(1):e32-e34. PubMed ID: 36205724
    [No Abstract]   [Full Text] [Related]  

  • 38. Characteristics of hair loss after COVID-19: A systematic scoping review.
    Czech T; Sugihara S; Nishimura Y
    J Cosmet Dermatol; 2022 Sep; 21(9):3655-3662. PubMed ID: 35801366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alopecia in patients with COVID-19: A systematic review and meta-analysis.
    Nguyen B; Tosti A
    JAAD Int; 2022 Jun; 7():67-77. PubMed ID: 35224518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute telogen effluvium triad after resolution.
    Contin LA; Rocha VB
    An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.